Eversept Partners, LP — 13F Holdings & Portfolio
CIK 1697013 · latest 13F-HR filed 2026-08-14
Eversept Partners, LP manages $1.93B in 13F-reported U.S. long-equity assets across 120 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are UTHR (8.09%), ABVX (6.32%), EHC (5.38%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 32 new positions and exited 21; 47 existing positions rose in reported value and 30 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 46.6%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 31, 2026.
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| MOGHTADERI, KAMRAN, (NMN) Control | MANAGING PRINCIPAL since Sep 2015 | 75% or more | Individual |
| ROSENSTRAUS, RON, AVI Control | CHIEF FINANCIAL OFFICER since Jan 2023 | Less than 5% | Individual |
| SHAH, RISHI, RASESH Control | PRESIDENT since Jan 2023 | Less than 5% | Individual |
| ZIHNALI, BALKIR, (NMN) Control | CHIEF COMPLIANCE OFFICER & CHIEF OPERATING OFFICER since Mar 2020 | Less than 5% | Individual |
| EVERSEPT 1 LLC | MEMBER since Nov 2016 | Less than 5% | Domestic Entity |
| MOGHTADERI, KAMRAN, (NMN) Control Indirect owner via EVERSEPT 1 LLC | MANAGING MEMBER since Nov 2016 | 75% or more | Individual |
Ownership & leadership changes · 5 filings with changes since Mar 31, 2016
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- ChangedZIHNALI, BALKIR, (NMN) · title CHIEF COMPLIANCE OFFICER → CHIEF COMPLIANCE OFFICER & CHIEF OPERATING OFFICER
- AddedROSENSTRAUS, RON, AVI · CHIEF FINANCIAL OFFICER · Less than 5% · control person
- AddedSHAH, RISHI, RASESH · PRESIDENT · Less than 5% · control person
- AddedZIHNALI, BALKIR, (NMN) · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- ChangedMOGHTADERI, KAMRAN, (NMN) · title CHIEF COMPLIANCE OFFICER, MANAGING MEMBER → MANAGING PRINCIPAL
- ChangedMOGHTADERI, KAMRAN, (NMN) · now a control person
- AddedEVERSEPT 1 LLC · MEMBER · Less than 5%
- AddedMOGHTADERI, KAMRAN, (NMN) · MANAGING MEMBER · 75% or more · indirect via EVERSEPT 1 LLC · control person
- ChangedMOGHTADERI, KAMRAN, (NMN) · title MANAGING MEMBER → CHIEF COMPLIANCE OFFICER, MANAGING MEMBER
- ListedMOGHTADERI, KAMRAN, (NMN) · MANAGING MEMBER · 75% or more
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- ENSIGN GROUP INC$93.5M +3144.9%
- ENCOMPASS HEALTH CORP$85.0M +452.8%
- TRAVERE THERAPEUTICS INC$29.3M +181.6%
- ABIVAX SA$17.7M +17.0%
- TENET HEALTHCARE CORP$15.8M +283.6%
Top Trims
- GSK PLC-$73.3M -74.4%
- NATERA INC-$29.2M -38.0%
- VAXCYTE INC-$17.1M -31.8%
- WELLTOWER INC-$16.0M -44.6%
- REPLIGEN CORP-$12.3M -86.2%
New Positions
- CARETRUST REIT INC$43.3M
- UNITEDHEALTH GROUP INC$21.3M
- COGENT BIOSCIENCES INC$19.0M
- INSMED INC$15.9M
- AMN HEALTHCARE SVCS INC$13.9M
Exited Positions
- HEALTHPEAK PROPERTIES INC$32.5M
- AVANTOR INC$23.3M
- QIAGEN NV$21.8M
- ICON PLC$7.6M
- AGIOS PHARMACEUTICALS INC$6.8M
Eversept Partners, LP Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $155.9M | 8.09% | 287,668 | SH |
| 2 | ABIVAX SA | ABVX | 00370M103 | $121.8M | 6.32% | 913,880 | SH |
| 3 | ENCOMPASS HEALTH CORP | EHC | 29261A100 | $103.8M | 5.38% | 1,026,919 | SH |
| 4 | ENSIGN GROUP INC | ENSG | 29358P101 | $96.5M | 5.01% | 602,079 | SH |
| 5 | VERA THERAPEUTICS INC | VERA | 92337R101 | $94.9M | 4.93% | 2,212,770 | SH |
| 6 | INVESCO QQQ TR Put | QQQ | 46090E103 | $72.6M | 3.77% | 98,600 | SH |
| 7 | CELLDEX THERAPEUTICS INC NEW | CLDX | 15117B202 | $66.5M | 3.45% | 1,785,941 | SH |
| 8 | SYNDAX PHARMACEUTICALS INC | SNDX | 87164F105 | $61.2M | 3.17% | 2,798,210 | SH |
| 9 | BROOKDALE SR LIVING INC | BKD | 112463104 | $54.6M | 2.84% | 3,396,470 | SH |
| 10 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $52.7M | 2.73% | 664,684 | SH |
| 11 | NATERA INC | NTRA | 632307104 | $47.7M | 2.48% | 175,807 | SH |
| 12 | TRAVERE THERAPEUTICS INC | TVTX | 89422G107 | $45.4M | 2.35% | 798,973 | SH |
| 13 | CARETRUST REIT INC | CTRE | 14174T107 | $43.3M | 2.24% | 1,072,015 | SH |
| 14 | HCA HEALTHCARE INC | HCA | 40412C101 | $38.3M | 1.99% | 98,252 | SH |
| 15 | VAXCYTE INC | PCVX | 92243G108 | $36.6M | 1.90% | 629,952 | SH |
| 16 | LIQUIDIA CORPORATION | LQDA | 53635D202 | $34.2M | 1.77% | 428,652 | SH |
| 17 | COMMUNITY HEALTH SYS INC NEW | CYH | 203668108 | $26.3M | 1.36% | 7,864,575 | SH |
| 18 | GSK PLC | GSK | 37733W204 | $25.3M | 1.31% | 481,833 | SH |
| 19 | CHEMED CORP NEW | CHE | 16359R103 | $24.5M | 1.27% | 52,523 | SH |
| 20 | ELI LILLY & CO | LLY | 532457108 | $24.1M | 1.25% | 20,116 | SH |
| 21 | GERON CORP | GERN | 374163103 | $24.0M | 1.24% | 18,717,422 | SH |
| 22 | VIKING THERAPEUTICS INC | VKTX | 92686J106 | $23.5M | 1.22% | 602,922 | SH |
| 23 | OMEGA HEALTHCARE INVS INC | OHI | 681936100 | $23.1M | 1.20% | 483,547 | SH |
| 24 | INSULET CORP | PODD | 45784P101 | $22.7M | 1.18% | 148,816 | SH |
| 25 | TENET HEALTHCARE CORP | THC | 88033G407 | $21.4M | 1.11% | 114,199 | SH |
| 26 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $21.3M | 1.10% | 51,145 | SH |
| 27 | WELLTOWER INC | WELL | 95040Q104 | $19.8M | 1.03% | 87,312 | SH |
| 28 | BETA BIONICS INC | BBNX | 08659B102 | $19.6M | 1.02% | 1,249,441 | SH |
| 29 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $19.0M | 0.98% | 490,235 | SH |
| 30 | BIOCRYST PHARMACEUTICALS INC | BCRX | 09058V103 | $18.7M | 0.97% | 1,865,653 | SH |
| 31 | MOLINA HEALTHCARE INC | MOH | 60855R100 | $18.4M | 0.96% | 80,594 | SH |
| 32 | PENNANT GROUP INC | PNTG | 70805E109 | $17.0M | 0.88% | 460,272 | SH |
| 33 | LTC PPTYS INC | LTC | 502175102 | $16.2M | 0.84% | 420,640 | SH |
| 34 | INSMED INC | INSM | 457669307 | $15.9M | 0.83% | 149,209 | SH |
| 35 | VIRIDIAN THERAPEUTICS INC | VRDN | 92790C104 | $15.3M | 0.79% | 831,142 | SH |
| 36 | BIOMARIN PHARMACEUTICAL INC | BMRN | 09061G101 | $14.3M | 0.74% | 249,607 | SH |
| 37 | AMN HEALTHCARE SVCS INC | AMN | 001744101 | $13.9M | 0.72% | 428,531 | SH |
| 38 | CELCUITY INC | CELC | 15102K100 | $13.4M | 0.69% | 127,931 | SH |
| 39 | PHARVARIS N V | PHVS | N69605108 | $13.4M | 0.69% | 386,383 | SH |
| 40 | CYTOMX THERAPEUTICS INC. | CTMX | 23284F105 | $13.3M | 0.69% | 3,558,497 | SH |
| 41 | HUMANA INC | HUM | 444859102 | $12.4M | 0.64% | 31,171 | SH |
| 42 | XENON PHARMACEUTICALS INC | XENE | 98420N105 | $11.9M | 0.62% | 196,532 | SH |
| 43 | CORVUS PHARMACEUTICALS INC | CRVS | 221015100 | $11.2M | 0.58% | 747,994 | SH |
| 44 | ASCENDIS PHARMA A/S | ASND | K08588103 | $11.1M | 0.58% | 41,621 | SH |
| 45 | BRUKER CORP | BRKR | 116794108 | $11.0M | 0.57% | 182,894 | SH |
| 46 | MODERNA INC | MRNA | 60770K107 | $10.7M | 0.55% | 152,122 | SH |
| 47 | STRUCTURE THERAPEUTICS INC | GPCR | 86366E106 | $10.5M | 0.55% | 196,302 | SH |
| 48 | INSMED INC Call | INSM | 457669307 | $10.3M | 0.53% | 96,600 | SH |
| 49 | DEFINIUM THERAPEUTICS INC | DFTX | 24477V105 | $10.2M | 0.53% | 217,185 | SH |
| 50 | COMPASS PATHWAYS PLC | CMPS | 20451W101 | $9.5M | 0.49% | 672,825 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $1.93B | 120 | 0001697013-26-000005 |
| 2026-03-31 | 2026-05-15 | $1.90B | 120 | 0001697013-26-000003 |
| 2025-12-31 | 2026-02-17 | $1.98B | 107 | 0001697013-26-000002 |
| 2025-09-30 | 2025-11-14 | $1.45B | 86 | 0001697013-25-000010 |
22ND FLOOR
NEW YORK, NY 10022